Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth <it>in vitro </it>and <it>in vivo</it>
<p>Abstract</p> <p>Background</p> <p>Medulloblastoma is the most common brain tumor in children, and its prognosis is worse than for many other common pediatric cancers. Survivors undergoing treatment suffer from serious therapy-related side effects. Thus, it is imperat...
Main Authors: | Olson James M, Fawcett Paul T, Maduskuie Victoria, Krauthauser Candice, Lee Seung, Rajasekaran Sigrid A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/144 |
Similar Items
-
HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
by: Chenxi Zhu, et al.
Published: (2023-09-01) -
Inhibition of HDAC3 Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice In Vivo and In Vitro
by: Bo Zhao, et al.
Published: (2019-01-01) -
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro.
by: Hongbiao Huang, et al.
Published: (2012-01-01) -
Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies
by: Huangyi Fang, et al.
Published: (2022-10-01) -
AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
by: Jing Cai, et al.
Published: (2023-01-01)